Natural Products Against COVID-19 Inflammation: A Mini-Review

Comb Chem High Throughput Screen. 2022;25(14):2358-2369. doi: 10.2174/1386207325666220128114547.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is a virus whose genetic material is positive single-stranded RNA, being responsible for coronavirus disease 2019 (COVID- 19), an infection that compromises the lungs and consequently the respiratory capacity of the infected individual, according to the WHO in November 2021, 249,743,428 cases were confirmed, of which 5,047,652 individuals died due to complications resulting from the infection caused by SARSCOV- 2. As the infection progresses, the individual may experience loss of smell and taste, as well as breathing difficulties, severe respiratory failure, multiple organ failure, and death. Due to this new epidemiological agent in March 2020 it was announced by the director general of the World Health Organization (WHO) a pandemic status, and with that, many research groups are looking for new therapeutic alternatives through synthetic and natural bioactives. This research is a literature review of some in silico studies involving natural products against COVID-19 inflammation published in 2020 and 2021. Work like this presents relevant information to the scientific community, boosting future research and encouraging the use of natural products for the search for new antivirals against COVID-19.

Keywords: COVID-19 inflammation; SARS-CoV-2; Virus infection; antivirals; molecular modeling database; natural products.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Products* / pharmacology
  • Biological Products* / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • Inflammation / drug therapy
  • Pandemics
  • SARS-CoV-2

Substances

  • Biological Products